中国1996—2014年肺癌经济负担研究系统评价

发布时间：2018-09-13 09:03

【摘要】：目的探讨中国1996—2014年肺癌经济负担研究状况,为肺癌防控措施相关评价及卫生决策提供参考依据。方法以癌症、经济负担、费用等为检索词,检索中国知网、万方和Pub Med数据库1996年1月1日—2014年12月31日发表的关于中国肺癌经济负担的文献,再按非肺癌相关文献等标准进行排除,对最终纳入的32篇文献进行摘录,所有费用数据均按照2013年我国医疗保健消费价格指数行贴现处理,且以均值表示,同时计算年均增长率。结果最终纳入的32篇文献中,基于住院患者和人群的研究分别有30和2篇;经济负担类型方面,关注直接经济负担、间接经济负担、直接和间接经济负担的文献分别有26、1和5篇;本研究分析结果显示,中国1996—2011年肺癌例均直接医疗费用为10 415~27 595元,年均增长率为2.2%(其中检查费、药品费和化验费用年均增长率分别为3.5%、-3.2%和2.2%);1997—2010年肺癌次均直接医疗费用为9 463~38 209元,年均增长率为-1.7%(其中检查费、药品费和化验费年均增长率分别为16.9%、-2.2%和17.3%);1996—2009年肺癌直接医疗日均费用为426~1 036元,年均增长率为6.3%;直接非医疗费用和间接费用因涵盖项目及方法差异,无法得出趋势数据。结论中国肺癌经济负担研究数据的收集及分析方法不一,例均和次均费用整体趋势不明显,但细化项目多呈增长趋势且幅度不同。
[Abstract]:Objective to study the economic burden of lung cancer in China from 1996 to 2014, and to provide reference for the evaluation and health decision of lung cancer prevention and control measures. Methods using cancer, economic burden and cost as the key words, we searched the literature on the economic burden of lung cancer published from January 1, 1996 to December 31, 2014 in China Zhiwang, Wanfang and Pub Med databases. Then excluded according to non-lung cancer related literature and other standards, the final included 32 articles were extracted. All the cost data were discounted according to the 2013 health care consumer price index in China, and expressed as the average value. At the same time, the average annual growth rate is calculated. Results of the 32 articles included, 30 and 2 were based on inpatient and population, respectively. In terms of economic burden types, direct economic burden and indirect economic burden were concerned. The results of this study show that the average direct medical cost of lung cancer cases in China from 1996 to 2011 was 10,4151,27,595 yuan, with an average annual growth rate of 2.2%. The average direct medical cost of lung cancer in 1997-2010 was 9,463,38,209 yuan, with an average annual growth rate of -1.7%. The average daily cost of direct medical treatment for lung cancer from 1996 to 2009 was 426m 1,036 yuan, with an average annual growth rate of 6.3%, and the direct non-medical cost and indirect cost could not obtain trend data because of the differences in items and methods. Conclusion the data collection and analysis methods of economic burden study on lung cancer in China are different, and the overall trend of average and sub-cost of lung cancer is not obvious, but most of the detailed items show an increasing trend and the range is different.
【作者单位】： 徐州医科大学公共卫生学院流行病学与卫生统计教研室;徐州市疾病预防与控制中心慢性非传染性疾病防治科;国家癌症中心/中国医学科学院肿瘤医院城市癌症早诊早治项目办公室;国家癌症中心/中国医学科学院肿瘤医院胸外科;江苏省疾病预防与控制中心慢性非传染性疾病防治所;
【基金】：国家自然科学青年基金(81402740;81773521;81602930) 科技部重大慢性非传染性疾病专项研究(2017YFC1308700;2017YFC1308705) 教育部高等学校博士学科点专项科研基金(20131106120014) 国家城市癌症早诊早治项目
【分类号】：R181.3;R734.2
，

本文编号：2240687